Daclatasvir dihydrochloride
Daclatasvir dihydrochloride is an oral HCV NS5A inhibitor used in combination therapies for chronic hepatitis C. It is a key research tool for studying viral replication mechanisms in both in vitro and in vivo models, with a clinical profile associated with minimal hepatotoxicity.
Product Specifications
CAS Number
1009119-65-6
Product Name Alternative
Daclatasvir, Daclatasvir dihydrochloride, Daclatasvir Dihydrochloride, antiviral, BMS 790052, BMS 790052 Dihydrochloride, BMS790052, BMS-790052, BMS790052 Dihydrochloride, BMS-790052 dihydrochloride, BMS-790052 Dihydrochloride, OATP1B1, OATP1B3, inhibit, JFH-1, NS5A, Inhibitor, EBP-883, EBP 883, EBP883, Hepatitis C virus, HCVProtease, HCV Protease, HCV NS5A, HCV, genotypes, replicon
Field of Research
Infectious Disease & Virology, Pharmacology & Drug Discovery, Protein Biochemistry
Purity
99.67% (May vary between batches)
Solubility
DMSO:55 mg/mL (67.75 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:1 mg/mL (1.23 mM)
Smiles
Cl.Cl.COC (=O) N[C@@H] (C (C) C) C (=O) N1CCC[C@H]1c1ncc ([nH]1) -c1ccc (cc1) -c1ccc (cc1) -c1cnc ([nH]1) [C@@H]1CCCN1C (=O) [C@@H] (NC (=O) OC) C (C) C
Molecular Formula
C40H52Cl2N8O6
Molecular Weight
811.8
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
